Immune checkpoint inhibitors Manipulating immune cell populations ex vivo CAR-T cells CAR-NK cells Tumor-infiltrating lymphocytes CD3-directed therapies Oncolytic viruses Targeting macrophages Personalised vaccines Cytokine